Refractive Ametropia
0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Bausch + LombNJ - Bridgewater
2 programsBL-3100-NBR03 multi-purpose solutionN/A1 trial
REVIVE Contact LensN/A1 trial
Active Trials
J&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Bausch + LombREVIVE Contact Lens
Bausch + LombBL-3100-NBR03 multi-purpose solution
AlconLID015385 soft contact lenses
Johnson & Johnsonetafilcon A control lens
Clinical Trials (4)
Total enrollment: 596 patients across 4 trials
1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses
Start: Oct 2023Est. completion: Dec 202326 patients
N/ACompleted
A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution
Start: Apr 2023Est. completion: Feb 2024295 patients
N/ACompleted
Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens
Start: Oct 2019Est. completion: Mar 2021
N/ACompleted
Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens
Start: Nov 2011Est. completion: Feb 2012275 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space